Allergan 1Q Revenues: $1.4 billion (+8%) 1Q Earnings: $14.4 million (earnings were $230.3 million 1Q12) Comments: Specialty pharmaceutical sales increased 8% to $1.2 billion. Botox/Neuromodulator sales were up 15% to $457.9 million. Eye Care Pharmaceutical sales were up 3% to $668.6 million. Medical devices sales increased 10% to $200.7 million. Facial Aesthetics sales were up 33% to $111.1 million. Earnings reflect loss on the sale of discontinued operations of $259.0 million....